Skip to main content

NEXGEL, Inc. (NXGL) Stock Forecast

Data as of Sep 20, 2026

Healthcare · Current price $0.28 (+7.34%)

Consensus Target
Upside
Analysts
1
Rating
Hold(3.00)

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

NXGL vs Sector & Market

MetricNXGLHealthcare AvgLarge Cap Avg
Analyst Rating3.002.252.42
Analyst Count1818
Target Upside+22217.1%+21.5%
P/E Ratio-1.593.7638.34

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$17M$17M$17M1
2027-12-31$25M$25M$25M1
2028-12-31$32M$32M$32M1
2029-12-31$41M$41M$41M1
2030-12-31$52M$52M$52M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-0.06$-0.06$-0.061
2027-12-31$0.23$0.23$0.231
2028-12-31$0.19$0.19$0.191
2029-12-31$0.30$0.30$0.301
2030-12-31$0.41$0.41$0.411

Frequently Asked Questions

What is the analyst consensus for NXGL?

The consensus among 1 analysts covering NEXGEL, Inc. (NXGL) is Hold with an average price target of N/A.

How many analysts cover NXGL?

1 analysts have issued ratings for NEXGEL, Inc. in the past 12 months.

Is NXGL a buy or sell right now?

Based on 1 analyst ratings, NXGL has a consensus rating of Hold (3.00/5) with a N/A upside to the consensus target of N/A.

What are the earnings estimates for NXGL?

Analysts estimate NXGL will report EPS of $-0.06 for the period ending 2026-12-31, with revenue estimated at $17M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.